| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,042 | $495.74 | $516.6K | 10,033 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 844 | $515.90 | $435.4K | 11,075 | May 18, 2026 | May 18, 2026 ↗ | View → |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 5,467 | — | — | 5,467 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,374 | — | — | 11,919 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,545 | — | — | 7,545 | May 15, 2025 | May 16, 2025 ↗ | View → |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,839 | — | — | 12,839 | May 15, 2025 | May 16, 2025 ↗ | View → |